Large-scale randomized controlled trials specifically for GHK-Cu monotherapy on hair loss have not been published
Understanding your genetic predispositions and baseline biomarkers empowers a more informed discussion with your provider about glutathione timing, formulation, and whether oral, compounded, or intravenous administration best supports your metabolic and antioxidant goals
This page is for education, not medical care
Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, U.S
The exact mechanisms of action of BPC-157 in Peptide Therapy are not yet fully understood, but several potential mechanisms have been proposed based on experimental studies
Since everyone biology varies, trying both peptides at different times can help identify which works better for a specific person